The University of Chicago Header Logo

Connection

Olatoyosi Odenike to Tumor Suppressor Protein p53

Back to Details
This is a "connection" page, showing publications Olatoyosi Odenike has written about Tumor Suppressor Protein p53.
Olatoyosi Odenike
Connection Strength
0.095
Tumor Suppressor Protein p53
  1. Pevonedistat with azacitidine in older patients with TP53-mutated AML: a phase 2 study with laboratory correlates. Blood Adv. 2023 06 13; 7(11):2360-2363.
    View in: PubMed
    Score: 0.048
  2. Eprenetapopt combined with venetoclax and azacitidine in TP53-mutated acute myeloid leukaemia: a phase 1, dose-finding and expansion study. Lancet Haematol. 2023 Apr; 10(4):e272-e283.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.